Francisco Partners has injected $30m into Kyruus, five months after the patient-matching platform developer received $42m in a series D round featuring Salesforce and Providence St Joseph.

Life sciences venture firm 4Bio Capital has secured the biopharmaceutical company as the first strategic backer for its second fund.

Solvay Ventures veteran Alexandre Ouimet-Storrs has joined Mercia alumna Nicola Broughton to form a medical cannabis-focused investment firm.

GCV Rising Star David Schulte has taken up a senior vice-president role to oversee McKesson’s strategic investment arm, after previous unit head Tom Rodgers ascended to chief strategy officer.

Søren Thinggaard Hansen, a 17 year-plus veteran of pension fund Industriens Pension, has joined Novo to launch a private equity program.

Sompo contributed to a $13.5m round for Binah.ai, developer of a mobile app that uses video to assess a user's physical health.

Takeda's R&D park is accepting membership applications for Japan VC Consortium, a life sciences-focused venture capital and corporate venturing engagement centre.

OHSU's CNS disorder drug developer has launched with $76m from investors co-led by Arch Venture Partners and Cowen Healthcare Investments.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Johnson & Johnson Innovation – JJDC returned for Cue Health’s $100m series C round as the medical diagnostics system developer seeks regulatory approval for its Covid-19 test.